Supplements

Non-motor outcomes are highly prevalent after stroke, with no significant differences between hospital and population settings except for bowel dysfunction.

A systematic review and meta-analysis of 357 prospective cohort studies (247,541 participants) found that adverse non-motor outcomes such as anxiety, depression, fatigue, and sleep disturbance are common after stroke. Pooled prevalence did not differ significantly between hospital-based and population-based studies, except for bowel dysfunction, which was higher in population-based studies (61% vs 47%). Use of non-validated outcome measures was associated with higher reported prevalence for several outcomes.

1 min readUpdated Jul 29, 20260 RCTs1 Meta-analysesView structured evidence →
Evidence Score47/100
Human RCT☆☆☆☆☆
Meta-analysis★★★☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.

Non-motor outcomes are highly prevalent after stroke, with no significant differences between hospital and population settings except for bowel dysfunction. The current body of evidence comprises 1 study and 1 meta-analysis. EvidenceHub rates the overall confidence at 47/100 (low).

The Claim

Non-motor outcomes are highly prevalent after stroke, with no significant differences between hospital and population settings except for bowel dysfunction.

This conclusion is most relevant to: Stroke survivors from 357 prospective cohort studies (mean age 64 years; 247 male-predominant studies; 55% ischemic stroke, 42% mixed, 3% intracerebral hemorrhage)..

What the Research Shows

The conclusion draws on 1 linked study. Highlights from the cited literature:

  • Non-motor Outcomes After Stroke: Updated Systematic Review and Meta-Analysis. (International journal of stroke : official journal of the International Stroke Society, 2026) —

How It Works

The proposed biological pathway:

  • Stroke leads to brain damage affecting non-motor pathways
  • Non-motor symptoms emerge post-stroke
  • Prevalence varies by measurement method and follow-up duration
  • Result: High prevalence of non-motor outcomes across settings

Who Might Benefit

Evidence fit by population:

  • Stroke survivors from 357 prospective cohort studies (mean age 64 years; 247 male-predominant studies; 55% ischemic stroke, 42% mixed, 3% intracerebral hemorrhage).

Limitations & Caveats

Important context when interpreting this evidence:

  • Substantial methodological heterogeneity across studies (I2 41%-99%)
  • Limited evidence on non-motor outcomes after intracerebral hemorrhage (only 3% of studies)
  • Frequent use of non-validated outcome measures (44.3% of studies)
  • Few studies assessed outcomes beyond 2 years post-stroke (12%)

Frequently Asked Questions

What are the most common non-motor outcomes after stroke?

The study examined 11 outcomes including anxiety, depression, apathy, fatigue, sleep disturbance, social participation, pain, bladder, bowel, and sexual dysfunction; all were highly prevalent.

Does the prevalence of non-motor outcomes differ between hospital and population settings?

No significant differences were found for most outcomes, except bowel dysfunction was more common in population-based studies (61% vs 47%).

How does the use of non-validated outcome measures affect reported prevalence?

Studies using non-validated measures reported significantly higher prevalence for anxiety, apathy, sleep disturbance, and bowel dysfunction.

What factors are associated with higher prevalence of non-motor outcomes?

Older age (>60 years), stroke due to intracerebral hemorrhage, and use of non-validated outcome measures were significantly associated with higher prevalence across multiple domains.

References

  1. 1.Ozkan H, Esmail T, Ambler G, Drummond A, Leff AP, Simister R, Werring D. “Non-motor Outcomes After Stroke: Updated Systematic Review and Meta-Analysis..” International journal of stroke : official journal of the International Stroke Society, 2026. PMID: 42504592 DOI: 10.1177/17474930261475966
Disclaimer: This article is auto-generated from structured research data for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.